Cellmid Ltd - Trending towards break-even
Cellmid Ltd (ASX:CDY)

Trending towards break-even


Accelerating consumer health revenue growth:

Consumer health revenue growth of 30% in FY2019, up from 25% in FY2018.

Improved operating results:

Consumer health operating results improved with a 42% reduction in operating loss to $0.7 million, down from $1.2 million in FY2018.

Investing for global growth:

Significant investment in senior management team, distribution channels, e-commerce and digital market capabilities plus operational efficiencies.

Guidance confirmed:

Cellmid is on track to reach operating profitability in the consumer health business in FY2020.

CEO's Summary

Maria Halasz

“FY2019 was a year of significant investment for Cellmid. We have expanded our distribution channels in the US and around the world, built our e-commerce and digital marketing infrastructure, and we have expanded our senior management capability for global growth. The benefit of these investments will flow through in FY2020 and beyond. We are now well positioned to take advantage of the large market opportunity for our first in class, best in class antiaging hair products.”

Maria Halasz
CEO, Cellmid Ltd

Download Announcement

View this announcement as well as our full profile on the company.

How do I invest?

Considering investing in Cellmid Ltd?
Here's how to get started.
Low Cost Brokerage ASX Cheapest ASX Trading Platform
  1. 1

    Create account

    Open an account with an online broker of your choice. If you do not have an existing broker, consider Vested Equities' A$9.50 flat fee platform.

    Sign up now »
  2. 2

    Search for ASX:CDY

    On your online investment platform search for the stock ticker code ASX:CDY to bring up the company's shares.

  3. 3

    Buy shares

    Place your order however you wish. If you need advice on buying or selling, you should seek the assistance of a full service financial adviser experienced in small cap equities.